$62.76
16.18% yesterday
NYSE, Oct 15, 10:19 pm CET

Hims & Hers Health Inc. Stock price

$62.76
+8.80 16.31% 1M
+33.30 113.03% 6M
+38.58 159.55% YTD
+39.96 175.26% 1Y
+58.42 1,346.08% 3Y
+52.28 498.86% 5Y
+52.96 540.41% 10Y
+52.96 540.41% 20Y
NYSE, Closing price Wed, Oct 15 2025
+8.74 16.18%

Key metrics

Basic
Market capitalization
$14.2b
Enterprise Value
$14.0b
Net debt
positive
Cash
$1.1b
Shares outstanding
225.8m
Valuation (TTM | estimate)
P/E
83.7 | 101.7
P/S
7.0 | 5.9
EV/Sales
7.0 | 5.9
EV/FCF
117.2
P/B
25.2
Financial Health
Equity Ratio
67.4%
Return on Equity
26.4%
ROCE
8.5%
ROIC
36.3%
Debt/Equity
1.7
Financials (TTM | estimate)
Revenue
$2.0b | $2.4b
EBITDA
$166.1m | $324.8m
EBIT
$136.9m | $147.0m
Net Income
$193.6m | $139.3m
Free Cash Flow
$119.5m
Growth (TTM | estimate)
Revenue
88.7% | 61.7%
EBITDA
526.4% | 281.7%
EBIT
821.9% | 116.2%
Net Income
969.6% | 10.5%
Free Cash Flow
33.5%
Margin (TTM | estimate)
Gross
76.2%
EBITDA
8.3% | 13.6%
EBIT
6.8%
Net
9.6% | 5.8%
Free Cash Flow
5.9%
More
EPS
$0.8
FCF per Share
$0.5
Short interest
38.9%
Employees
2k
Rev per Employee
$900.0k
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Hims & Hers Health Inc. forecast:

8x Buy
40%
10x Hold
50%
2x Sell
10%

Analyst Opinions

20 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
40%
Hold
50%
Sell
10%

Financial data from Hims & Hers Health Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,014 2,014
89% 89%
100%
- Direct Costs 479 479
152% 152%
24%
1,534 1,534
75% 75%
76%
- Selling and Administrative Expenses 1,397 1,397
62% 62%
69%
- Research and Development Expense - -
-
-
166 166
526% 526%
8%
- Depreciation and Amortization 29 29
150% 150%
1%
EBIT (Operating Income) EBIT 137 137
822% 822%
7%
Net Profit 194 194
970% 970%
10%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Positive
The Motley Fool
about 9 hours ago
Healthcare products specialist Hims & Hers Health (HIMS 16.20%) stock passed the most crucial exam of all on Wednesday, as investors gave it the thumbs-up. The shares ended the day more than 16% higher in price, thanks to the company's reveal that it's pushing into a potentially lucrative new segment.
Positive
Market Watch
about 13 hours ago
Hims & Hers is taking aim at menopause and perimenopause in an attempt to tap in to a huge and potentially highly lucrative market.
Positive
WSJ
about 19 hours ago
The company expects the new specialty to help the Hers unit to surpass $1 billion in annual revenue next year.
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,637
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today